| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.44B | 3.34B | 3.27B | 3.31B | 2.71B | 1.81B |
| Gross Profit | 1.16B | 1.16B | 573.09M | 1.57B | 972.61M | 604.57M |
| EBITDA | 461.50M | 444.34M | 632.53M | 1.13B | 624.45M | 250.16M |
| Net Income | -67.65M | -69.40M | 263.23M | 645.83M | 287.47M | -81.31M |
Balance Sheet | ||||||
| Total Assets | 5.67B | 5.22B | 5.00B | 4.12B | 3.52B | 3.35B |
| Cash, Cash Equivalents and Short-Term Investments | 12.04M | 211.84M | 76.98M | 692.16M | 328.37M | 266.44M |
| Total Debt | 1.09B | 843.41M | 201.11M | 23.57M | 86.47M | 315.46M |
| Total Liabilities | 1.88B | 1.42B | 1.13B | 507.42M | 541.82M | 676.00M |
| Stockholders Equity | 3.79B | 3.80B | 3.87B | 3.61B | 2.98B | 2.67B |
Cash Flow | ||||||
| Free Cash Flow | -652.58M | 399.09M | -605.69M | 349.82M | 347.13M | 380.96M |
| Operating Cash Flow | 112.34M | 399.09M | 313.54M | 925.95M | 549.10M | 454.32M |
| Investing Cash Flow | -511.78M | -859.86M | -1.10B | -475.12M | -210.25M | -64.33M |
| Financing Cash Flow | 204.85M | 587.23M | 160.65M | -88.92M | -245.73M | -155.91M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | ₹9.84B | 17.66 | ― | 0.52% | 28.67% | 50.12% | |
66 Neutral | ₹7.29B | 11.95 | ― | 1.14% | 8.27% | 195.27% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
60 Neutral | ₹8.00B | 22.24 | ― | 1.23% | 0.69% | -7.54% | |
60 Neutral | ₹6.22B | 10.26 | ― | 0.81% | -4.92% | 1.29% | |
58 Neutral | ₹5.24B | -33.35 | ― | 0.28% | 5.19% | -152.09% | |
54 Neutral | ₹7.62B | 3.95 | ― | 0.82% | -2.41% | 178.19% |
Chemfab Alkalis Limited has submitted and published an investor presentation for the quarter ended December 31, 2025, as a voluntary disclosure to stock exchanges and on its website, aiming to provide shareholders and market participants with updated financial and business information. The move underscores the company’s emphasis on transparency and investor communication, offering stakeholders deeper insight into its quarterly performance and strategic position in the chemical sector.